Murray Stahl's GSK Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 24,892 shares of GSK plc (GSK) worth $1.22 M, representing 0.02% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 13,027 shares. Largest reduction occurred in Q3 2025, reducing 12,027 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Murray Stahl
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -473 | Reduce 1.86% | 24,892 | $49.04 |
| Q3 2025 | -12,027 | Reduce 32.16% | 25,365 | $43.16 |
| Q2 2025 | -1,273 | Reduce 3.29% | 37,392 | $38.40 |
| Q1 2025 | -1,200 | Reduce 3.01% | 38,665 | $38.74 |
| Q4 2024 | +1,673 | Add 4.38% | 39,865 | $33.82 |
| Q3 2024 | +13,027 | Add 51.77% | 38,192 | $40.88 |
| Q4 2023 | +227 | Add 0.91% | 25,165 | $37.06 |
| Q3 2023 | +1,100 | Add 4.61% | 24,938 | $36.25 |
| Q2 2023 | +1,000 | Add 4.38% | 23,838 | $35.64 |
| Q1 2023 | +9,560 | Add 72.00% | 22,838 | $35.58 |
| Q3 2022 | +13,278 | New Buy | 13,278 | $29.45 |
Murray Stahl's GSK plc Investment FAQs
Murray Stahl first purchased GSK plc (GSK) in Q3 2022, acquiring 13,278 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held GSK plc (GSK) for 14 quarters since Q3 2022.
Murray Stahl's largest addition to GSK plc (GSK) was in Q3 2022, adding 13,278 shares worth $391,000.
According to the latest 13F filing for Q4 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 24,892 shares of GSK plc (GSK), valued at approximately $1.22 M.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 0.02% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings.
Murray Stahl's peak holding in GSK plc (GSK) was 39,865 shares, as reported at the end of Q4 2024.